Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$107.14
-0.1%
$104.77
$80.64
$108.94
$158.76B0.655.74 million shs4.06 million shs
GSK PLC Sponsored ADR stock logo
GSK
GSK
$40.41
+2.0%
$38.51
$31.72
$44.19
$82.30B0.533.23 million shs6.54 million shs
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$420.68
+2.2%
$380.14
$289.98
$420.98
$98.43B1.411.06 million shs1.06 million shs
Zoetis Inc. stock logo
ZTS
Zoetis
$153.15
0.0%
$153.16
$139.70
$200.33
$67.87B0.882.30 million shs1.90 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.00%+1.50%+3.80%+7.09%+31.30%
GSK PLC Sponsored ADR stock logo
GSK
GSK
0.00%+1.84%+7.02%-1.10%-7.47%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
0.00%+4.10%+10.17%+12.73%+8.43%
Zoetis Inc. stock logo
ZTS
Zoetis
0.00%-2.11%+3.94%-6.99%-19.07%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$107.14
-0.1%
$104.77
$80.64
$108.94
$158.76B0.655.74 million shs4.06 million shs
GSK PLC Sponsored ADR stock logo
GSK
GSK
$40.41
+2.0%
$38.51
$31.72
$44.19
$82.30B0.533.23 million shs6.54 million shs
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$420.68
+2.2%
$380.14
$289.98
$420.98
$98.43B1.411.06 million shs1.06 million shs
Zoetis Inc. stock logo
ZTS
Zoetis
$153.15
0.0%
$153.16
$139.70
$200.33
$67.87B0.882.30 million shs1.90 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.00%+1.50%+3.80%+7.09%+31.30%
GSK PLC Sponsored ADR stock logo
GSK
GSK
0.00%+1.84%+7.02%-1.10%-7.47%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
0.00%+4.10%+10.17%+12.73%+8.43%
Zoetis Inc. stock logo
ZTS
Zoetis
0.00%-2.11%+3.94%-6.99%-19.07%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Corporation stock logo
BSX
Boston Scientific
3.04
Buy$117.509.67% Upside
GSK PLC Sponsored ADR stock logo
GSK
GSK
1.86
Reduce$37.38-7.51% Downside
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
2.53
Moderate Buy$401.83-4.48% Downside
Zoetis Inc. stock logo
ZTS
Zoetis
2.50
Moderate Buy$202.4332.18% Upside

Current Analyst Ratings Breakdown

Latest HCA, GSK, ZTS, and BSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$444.00
8/14/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$380.00 ➝ $423.00
8/14/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$385.00 ➝ $375.00
8/11/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$210.00 ➝ $215.00
8/4/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$360.00 ➝ $370.00
7/28/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformPeer Perform
7/28/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$404.00 ➝ $401.00
7/28/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$416.00 ➝ $390.00
7/28/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$410.00 ➝ $400.00
7/24/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
7/24/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetStrong-Buy$121.00 ➝ $124.00
(Data available from 9/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$16.75B9.48$3.65 per share29.37$14.93 per share7.18
GSK PLC Sponsored ADR stock logo
GSK
GSK
$40.10B2.05$5.57 per share7.26$8.07 per share5.01
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$70.60B1.39$35.89 per share11.72$2.19 per share192.09
Zoetis Inc. stock logo
ZTS
Zoetis
$9.26B7.33$7.06 per share21.68$10.57 per share14.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$1.85B$1.6863.7833.172.5813.55%19.21%10.62%10/22/2025 (Estimated)
GSK PLC Sponsored ADR stock logo
GSK
GSK
$3.29B$2.1618.718.692.0310.81%49.22%11.31%10/29/2025 (Estimated)
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$5.76B$23.7917.6815.011.328.21%-7,363.11%10.35%10/24/2025 (Estimated)
Zoetis Inc. stock logo
ZTS
Zoetis
$2.49B$5.8126.3622.692.4627.83%56.90%19.54%11/3/2025 (Estimated)

Latest HCA, GSK, ZTS, and BSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Zoetis Inc. stock logo
ZTS
Zoetis
$1.62$1.76+$0.14$1.61$2.41 billion$2.46 billion
7/30/2025Q2 2025
GSK PLC Sponsored ADR stock logo
GSK
GSK
$1.12$1.23+$0.11$0.94$7.92 billion$10.64 billion
7/25/2025Q2 2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$6.20$6.84+$0.64$6.83$18.49 billion$18.61 billion
7/23/2025Q2 2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.72$0.75+$0.03$0.53$4.89 billion$5.06 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
GSK PLC Sponsored ADR stock logo
GSK
GSK
$1.684.16%N/A77.78%N/A
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$2.880.68%N/A12.11%6 Years
Zoetis Inc. stock logo
ZTS
Zoetis
$2.001.31%N/A34.42%14 Years

Latest HCA, GSK, ZTS, and BSX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/1/2100
GSK PLC Sponsored ADR stock logo
GSK
GSK
quarterly$0.42064.3%8/15/20258/15/202510/9/2025
7/25/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
quarterly$0.720.85%9/16/20259/16/20259/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.49
1.37
0.82
GSK PLC Sponsored ADR stock logo
GSK
GSK
1.07
0.87
0.57
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
69.07
0.98
0.86
Zoetis Inc. stock logo
ZTS
Zoetis
1.05
1.76
1.04

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
GSK PLC Sponsored ADR stock logo
GSK
GSK
15.74%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
62.73%
Zoetis Inc. stock logo
ZTS
Zoetis
92.80%

Insider Ownership

CompanyInsider Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.50%
GSK PLC Sponsored ADR stock logo
GSK
GSK
10.00%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
1.30%
Zoetis Inc. stock logo
ZTS
Zoetis
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
53,0001.48 billion1.47 billionOptionable
GSK PLC Sponsored ADR stock logo
GSK
GSK
68,6292.04 billion1.83 billionOptionable
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
316,000233.99 million230.95 millionOptionable
Zoetis Inc. stock logo
ZTS
Zoetis
13,800443.18 million442.47 millionOptionable

Recent News About These Companies

Eventide Asset Management LLC Takes Position in Zoetis Inc. $ZTS
Curi RMB Capital LLC Sells 43,964 Shares of Zoetis Inc. $ZTS
Zoetis Inc. $ZTS Shares Acquired by AQR Capital Management LLC
Amundi Has $575.69 Million Position in Zoetis Inc. $ZTS
First Manhattan CO. LLC. Sells 1,969 Shares of Zoetis Inc. $ZTS
Is Zoetis Stock Underperforming the Nasdaq?
PDT Partners LLC Lowers Holdings in Zoetis Inc. $ZTS

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Boston Scientific stock logo

Boston Scientific NYSE:BSX

$107.14 -0.15 (-0.14%)
Closing price 09/5/2025 03:59 PM Eastern
Extended Trading
$106.19 -0.95 (-0.89%)
As of 04:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

GSK stock logo

GSK NYSE:GSK

$40.41 +0.80 (+2.02%)
Closing price 09/5/2025 03:59 PM Eastern
Extended Trading
$39.97 -0.44 (-1.09%)
As of 04:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

HCA Healthcare stock logo

HCA Healthcare NYSE:HCA

$420.68 +9.09 (+2.21%)
Closing price 09/5/2025 03:59 PM Eastern
Extended Trading
$424.00 +3.32 (+0.79%)
As of 04:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Zoetis stock logo

Zoetis NYSE:ZTS

$153.15 -0.05 (-0.03%)
Closing price 09/5/2025 03:59 PM Eastern
Extended Trading
$153.28 +0.13 (+0.09%)
As of 04:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.